STXS EBITDA | STEREOTAXIS, INC.

STEREOTAXIS, INC. (STXS) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$4.57M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$5.98M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$6.56M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$3.98M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2021-06-30 to 2021-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$4.57M	(m)	$7.67M	(m)	(m)	-$3.67M*	(m)	$2.39M	(m)	(m)
2026-03-31	Reported	(m)	-$5.98M	(m)	$6.29M	(m)	(m)	-$3.44M	(m)	$2.40M	(m)	(m)
2025-09-30	Reported	(m)	-$6.56M	(m)	$7.46M	(m)	(m)	-$4.20M*	(m)	$2.55M	(m)	(m)
2025-06-30	Reported	(m)	-$3.98M	(m)	$8.80M	(m)	(m)	-$3.73M*	(m)	$1.78M	(m)	(m)
2025-03-31	Reported	(m)	-$5.93M	(m)	$7.47M	(m)	(m)	-$1.78M	(m)	$2.35M	(m)	(m)
2024-09-30	Reported	(m)	-$6.34M	(m)	$9.20M	(m)	(m)	-$4.33M*	(m)	$2.45M	(m)	(m)
2024-06-30	Reported	(m)	-$6.02M	(m)	$4.50M	(m)	(m)	-$3.09M*	(m)	$2.27M	(m)	(m)
2024-03-31	Reported	(m)	-$4.75M	(m)	$6.88M	(m)	(m)	-$2.35M	(m)	$2.24M	(m)	(m)
2023-09-30	Reported	(m)	-$5.64M	(m)	$7.80M	(m)	(m)	-$967.00K*	(m)	$2.67M	(m)	(m)
2023-06-30	Reported	(m)	-$5.28M	(m)	$7.86M	(m)	(m)	-$2.93M*	(m)	$2.65M	(m)	(m)
2023-03-31	Reported	(m)	-$5.62M	(m)	$6.55M	(m)	(m)	-$2.80M	(m)	$2.75M	(m)	(m)
2022-09-30	Reported	(m)	-$5.05M	(m)	$7.66M	(m)	(m)	-$2.53M*	(m)	$2.82M	(m)	(m)
2022-06-30	Reported	(m)	-$5.18M	(m)	$6.15M	(m)	(m)	-$1.14M*	(m)	$2.89M	(m)	(m)
2022-03-31	Reported	(m)	-$4.09M	(m)	$7.04M	(m)	(m)	-$2.19M	(m)	$2.45M	(m)	(m)
2021-09-30	Reported	(m)	-$4.62M	(m)	$9.11M	(m)	(m)	-$1.46M*	(m)	$2.50M	(m)	(m)
2021-06-30	Reported	-$1.79M	(m)	(m)	(m)	-19.79%	(m)	$34.00K*	(m)	$2.72M	(m)	(m)
2021-03-31	Reported	(m)	-$1.53M	(m)	$8.62M	(m)	(m)	-$305.00K	(m)	$2.37M	(m)	(m)
2020-09-30	Reported	(m)	-$1.56M	(m)	$8.70M	(m)	(m)	-$482.98K*	(m)	$1.95M	(m)	(m)
2020-06-30	Reported	(m)	-$1.92M	(m)	$5.35M	(m)	(m)	-$1.17M*	(m)	$1.98M	(m)	(m)
2020-03-31	Reported	(m)	-$2.05M	(m)	$5.76M	(m)	(m)	-$2.17M	(m)	$2.11M	(m)	(m)
2019-09-30	Reported	(m)	-$41.21K	(m)	$8.20M	(m)	(m)	-$405.85K*	(m)	$1.75M	(m)	(m)
2019-06-30	Reported	(m)	-$1.46M	(m)	$6.80M	(m)	(m)	-$518.94K*	(m)	$2.70M	(m)	(m)
2019-03-31	Reported	(m)	-$2.14M	(m)	$7.01M	(m)	(m)	-$1.78M	(m)	$2.96M	(m)	(m)
2018-09-30	Reported	(m)	-$113.78K	(m)	$7.56M	(m)	(m)	-$238.35K*	(m)	$2.00M	(m)	(m)
2018-06-30	Reported	(m)	-$626.06K	(m)	$7.55M	(m)	(m)	$490.23K*	(m)	$2.03M	(m)	(m)
2018-03-31	Reported	(m)	-$1.13M	(m)	$6.97M	(m)	(m)	-$2.02M	(m)	$1.96M	(m)	(m)
2017-09-30	Reported	(m)	$167.80K	(m)	(m)	(m)	(m)	-$491.31K*	(m)	$1.62M	(m)	(m)
2017-06-30	Reported	(m)	-$434.78K	(m)	(m)	(m)	(m)	-$713.20K*	(m)	$1.76M	(m)	(m)
2017-03-31	Reported	(m)	-$1.90M	(m)	$6.98M	(m)	(m)	-$2.67M	(m)	$1.60M	(m)	(m)
2016-09-30	Reported	(m)	-$1.17M	(m)	(m)	(m)	(m)	(m)	(m)	$1.30M	(m)	(m)
2016-06-30	Reported	(m)	-$1.64M	(m)	(m)	(m)	(m)	(m)	(m)	$1.42M	(m)	(m)
2016-03-31	Reported	(m)	-$1.49M	(m)	(m)	(m)	(m)	(m)	(m)	$1.47M	(m)	(m)
2015-09-30	Reported	(m)	-$907.48K	(m)	(m)	(m)	(m)	(m)	(m)	$1.49M	(m)	(m)
2015-06-30	Reported	(m)	-$1.72M	(m)	(m)	(m)	(m)	(m)	(m)	$1.42M	(m)	(m)
2015-03-31	Reported	(m)	-$1.41M	(m)	(m)	(m)	(m)	(m)	(m)	$1.49M	(m)	(m)
2014-09-30	Reported	(m)	-$1.18M	(m)	(m)	(m)	(m)	(m)	(m)	$1.21M	(m)	(m)
2014-06-30	Reported	(m)	-$2.29M	(m)	(m)	(m)	(m)	(m)	(m)	$1.31M	(m)	(m)
2014-03-31	Reported	(m)	-$2.23M	(m)	(m)	(m)	(m)	(m)	(m)	$1.50M	(m)	(m)
2013-09-30	Reported	(m)	-$1.07M	(m)	(m)	(m)	(m)	(m)	(m)	$1.30M	(m)	(m)
2013-06-30	Reported	(m)	-$1.75M	(m)	(m)	(m)	(m)	-$2.14M*	(m)	$1.48M	(m)	(m)
2013-03-31	Reported	(m)	-$3.59M	(m)	(m)	(m)	(m)	-$1.15M	(m)	$1.53M	(m)	(m)
2012-09-30	Reported	(m)	-$934.51K	(m)	(m)	(m)	(m)	-$3.63M*	(m)	$1.90M	(m)	(m)
2012-06-30	Reported	(m)	-$4.64M	(m)	(m)	(m)	(m)	-$4.19M*	(m)	$2.20M	(m)	(m)
2012-03-31	Reported	(m)	-$4.18M	(m)	(m)	(m)	(m)	-$4.22M	(m)	$2.83M	(m)	(m)
2011-09-30	Reported	(m)	-$9.06M	(m)	(m)	(m)	(m)	-$5.20M*	(m)	$3.53M	(m)	(m)
2011-06-30	Reported	(m)	-$9.54M	(m)	(m)	(m)	(m)	-$4.75M*	(m)	$3.31M	(m)	(m)
2011-03-31	Reported	(m)	-$8.76M	(m)	(m)	(m)	(m)	-$10.01M	(m)	$3.39M	(m)	(m)
2010-09-30	Reported	(m)	-$3.59M	(m)	(m)	(m)	(m)	-$950.93K*	(m)	$2.87M	(m)	(m)
2010-06-30	Reported	(m)	-$5.69M	(m)	(m)	(m)	(m)	(m)	(m)	$3.36M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$22.11M	(m)	$32.38M	(m)	(m)	-$13.69M	(m)	$9.38M	(m)	(m)
2024-12-31	Reported	(m)	-$24.74M	(m)	$26.92M	(m)	(m)	-$8.50M	(m)	$9.76M	(m)	(m)
2023-12-31	Reported	(m)	-$21.84M	(m)	$26.77M	(m)	(m)	-$9.14M	(m)	$10.27M	(m)	(m)
2022-12-31	Reported	(m)	-$18.78M	(m)	$28.15M	(m)	(m)	-$8.41M	(m)	$10.56M	(m)	(m)
2021-12-31	Reported	(m)	-$12.89M	(m)	$35.02M	(m)	(m)	-$2.95M	(m)	$10.20M	(m)	(m)
2020-12-31	Reported	(m)	-$6.71M	(m)	$26.63M	(m)	(m)	-$3.51M	(m)	$8.14M	(m)	(m)
2019-12-31	Reported	(m)	-$4.83M	(m)	$28.90M	(m)	(m)	-$4.62M	(m)	$9.02M	(m)	(m)
2018-12-31	Reported	(m)	-$2.46M	(m)	$29.35M	(m)	(m)	-$2.55M	(m)	$8.22M	(m)	(m)
2017-12-31	Reported	(m)	-$5.92M	(m)	(m)	(m)	(m)	-$4.67M	(m)	$6.70M	(m)	(m)
2016-12-31	Reported	(m)	-$6.43M	(m)	(m)	(m)	(m)	(m)	(m)	$5.49M	(m)	(m)
2015-12-31	Reported	(m)	-$5.41M	(m)	(m)	(m)	(m)	(m)	(m)	$6.25M	(m)	(m)
2014-12-31	Reported	(m)	-$5.38M	(m)	(m)	(m)	(m)	(m)	(m)	$5.16M	(m)	(m)
2013-12-31	Reported	(m)	-$8.84M	(m)	(m)	(m)	(m)	(m)	(m)	$5.67M	(m)	(m)
2012-12-31	Reported	(m)	-$10.63M	(m)	(m)	(m)	(m)	-$12.12M	(m)	$8.41M	(m)	(m)
2011-12-31	Reported	(m)	-$31.94M	(m)	(m)	(m)	(m)	-$31.57M	(m)	$12.89M	(m)	(m)
2010-12-31	Reported	(m)	-$18.96M	(m)	(m)	(m)	(m)	-$18.91M	(m)	$12.24M	(m)	(m)
2009-12-31	Reported	(m)	-$23.84M	(m)	(m)	(m)	(m)	-$22.31M	(m)	$14.26M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Vivani Medical, Inc. (VANI)	United States	$0.111B
electroCore, Inc. (ECOR)	United States	$0.102B
Neuraxis, INC (NRXS)	United States	$0.097B
Nexalin Technology, Inc. (NXL)	United States	$0.094B
EDAP TMS SA (FOCL)		$0.171B
Streamex Corp. (STEX)	United States	$0.089B	-0.19
Outset Medical, Inc. (OM)	United States	$0.059B	-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)	United States	$0.052B
QT IMAGING HOLDINGS, INC. (QTI)	United States	$0.037B
Electromed, Inc. (ELMD)	United States	$0.233B	31.13